BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35063003)

  • 1. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
    Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
    J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
    Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
    Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.
    Hassan G; Afify SM; Zahra MH; Nawara HM; Kumon K; Iwasaki Y; Salomon DS; Seno A; Seno M
    Cytotechnology; 2023 Jun; 75(3):243-253. PubMed ID: 37181678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
    Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
    PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
    Hassan G; Zahra MH; Seno A; Seno M
    Sci Rep; 2022 Feb; 12(1):2711. PubMed ID: 35177646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.
    Shen HF; Li YL; Huang SH; Xia JW; Yao ZF; Xiao GF; Zhou Y; Li YC; Shi JW; Lin XL; Zhao WT; Sun Y; Tian YG; Jia JS; Xiao D
    Aging (Albany NY); 2022 May; 14(10):4445-4458. PubMed ID: 35575836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Embryonic Stem Cells/Induced Pluripotent Stem Cells Induces Effective Immunity against Ovarian Tumor-Initiating Cells in Mice.
    Yu F; Zhang Z; Chang X; Ye X; Cheng H; Li Y; Cui H
    Stem Cells Int; 2023; 2023():8188324. PubMed ID: 38058983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells.
    Xu Y; Afify SM; Du J; Liu B; Hassan G; Wang Q; Li H; Liu Y; Fu X; Zhu Z; Chen L; Seno M
    Sci Rep; 2022 Jan; 12(1):347. PubMed ID: 35013447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of Dsg2 confered stem cells with malignancy through wnt/β-catenin signaling pathway.
    Chen L; Liu Y; Xu Y; Afify SM; Gao A; Du J; Liu B; Fu X; Liu Y; Yan T; Zhu Z; Seno M
    Exp Cell Res; 2023 Jan; 422(1):113416. PubMed ID: 36375513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts.
    Liu J; Ashton MP; Sumer H; O'Bryan MK; Brodnicki TC; Verma PJ
    Diabetes; 2011 May; 60(5):1393-8. PubMed ID: 21464439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages derived from cancer stem cells.
    Osman A; Oze M; Afify SM; Hassan G; El-Ghlban S; Nawara HM; Fu X; Zahra MH; Seno A; Winer I; Salomon DS; Seno M
    Acta Histochem; 2020 Dec; 122(8):151628. PubMed ID: 32992123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells.
    Matsu-ura T; Sasaki H; Okada M; Mikoshiba K; Ashraf M
    Stem Cell Res Ther; 2016 Feb; 7():30. PubMed ID: 26880084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotency and oncogenic transformation are related processes.
    Riggs JW; Barrilleaux BL; Varlakhanova N; Bush KM; Chan V; Knoepfler PS
    Stem Cells Dev; 2013 Jan; 22(1):37-50. PubMed ID: 22998387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.
    Ning X; Du Y; Ben Q; Huang L; He X; Gong Y; Gao J; Wu H; Man X; Jin J; Xu M; Li Z
    Cell Cycle; 2016; 15(3):403-12. PubMed ID: 26709750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
    Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
    Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
    Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
    Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel model of liver cancer stem cells developed from induced pluripotent stem cells.
    Afify SM; Sanchez Calle A; Hassan G; Kumon K; Nawara HM; Zahra MH; Mansour HM; Khayrani AC; Alam MJ; Du J; Seno A; Iwasaki Y; Seno M
    Br J Cancer; 2020 Apr; 122(9):1378-1390. PubMed ID: 32203212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method to Convert Stem Cells into Cancer Stem Cells.
    Afify SM; Chen L; Yan T; Calle AS; Nair N; Murakami C; Zahra MH; Okada N; Iwasaki Y; Seno A; Seno M
    Methods Protoc; 2019 Aug; 2(3):. PubMed ID: 31426391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.